» Articles » PMID: 23170274

Tumor-infiltrating B Cells: The Ignored Players in Tumor Immunology

Overview
Journal Oncoimmunology
Date 2012 Nov 22
PMID 23170274
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

B cells infiltrating into solid tumors are poorly investigated despite their described positive prognostic value. Whether this antitumor potential comes from either the antigen presentation or the antibody production capacity of B cells, or both, is unknown. Our recently published method on tumor-infiltrating B lymphocyte cloning may prove helpful in unraveling the actual relevance of these cells for tumor development and response to therapy.

Citing Articles

Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement.

Azizi A, Mehdipour F, Samadi M, Rasolmali R, Talei A, Ghaderi A BMC Immunol. 2024; 25(1):25.

PMID: 38702630 PMC: 11067195. DOI: 10.1186/s12865-024-00620-4.


Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk.

Shea A, Heffron C, Grieco J, Roberts P, Schmelz E Front Immunol. 2024; 14:1323399.

PMID: 38264656 PMC: 10803595. DOI: 10.3389/fimmu.2023.1323399.


Comprehensive characterization and database construction of immune repertoire in the largest Chinese glioma cohort.

Wang L, Xu Z, Zhang W, Li L, Liu X, Zhang J iScience. 2024; 27(1):108661.

PMID: 38205245 PMC: 10777385. DOI: 10.1016/j.isci.2023.108661.


Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.

Zareinejad M, Mehdipour F, Roshan-Zamir M, Faghih Z, Ghaderi A Cancers (Basel). 2023; 15(19).

PMID: 37835465 PMC: 10571747. DOI: 10.3390/cancers15194771.


The involvement of homeobox-C 4 in predicting prognosis and unraveling immune landscape across multiple cancers integrated analysis.

Xiao J, Li Y, Liu Y, Chen Y, He Z, Peng S Front Genet. 2022; 13:1021473.

PMID: 36276951 PMC: 9581313. DOI: 10.3389/fgene.2022.1021473.


References
1.
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View

2.
Pavoni E, Monteriu G, Santapaola D, Petronzelli F, Anastasi A, Pelliccia A . Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. BMC Biotechnol. 2007; 7:70. PMC: 2175506. DOI: 10.1186/1472-6750-7-70. View

3.
Coronella-Wood J, Hersh E . Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother. 2003; 52(12):715-38. PMC: 11033039. DOI: 10.1007/s00262-003-0409-4. View

4.
Erdag G, Schaefer J, Smolkin M, Deacon D, Shea S, Dengel L . Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 2012; 72(5):1070-80. PMC: 3306813. DOI: 10.1158/0008-5472.CAN-11-3218. View

5.
Maletzki C, Jahnke A, Ostwald C, Klar E, Prall F, Linnebacher M . Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG. PLoS One. 2012; 7(2):e32639. PMC: 3290587. DOI: 10.1371/journal.pone.0032639. View